This named Young Investigator Award was established in 2005 to celebrate the life, commitment and passion of Professor Panos Ioannou (1951-2005). Panos was a founding member of the Australasian Gene and Cell Therapy Society (AGCTS) who dedicated his career to developing novel therapies for thalassaemia and other inherited neurological and metabolic diseases. A renowned global leader in molecular biology and genetics, his ground-breaking research continues today through the many young researchers he trained. His colleague and mentor, Professor Bob Williamson says “Panos was irrepressible. He would get knocked down and bounce right back up. He was the most positive person I have ever met. His glass was always more than half full, it was full to the brim and overflowing”.

The Panos Ioannou Young Investigator Award is announced at the biennial AGCTS Conference. At the closing session prizes are awarded to student members in recognition of their excellence in research and communication. Postdoctoral fellows within 6 years of PhD graduation who are presenting an abstract and hold current AGCTS membership are eligible to apply. Career disruptions will be considered and women are encouraged to apply. Winners will be featured on this page and invited to write for the AGCTS blog and newsletter. Congratulations to all!

2015 – Dr Chantelle McIntyre

Chantelle McIntyre recently completed her PhD thesis at The University of Adelaide and is now a postdoctoral fellow in the Adelaide Cystic Fibrosis Gene Therapy Research group. She presented her PhD project which developed lentiviral gene therapy for the metabolic disorder Sanfilippo Syndrome.

2013 – Cindy Kok

It was a great honour and privilege to receive the Panos Ioannou Young Investigator Award. I would like to thank the AGTS Executive Committee for their support and also my supervisor Professor Ian Alexander for encouraging me to present my work at this years conference. The prize money was used for travel costs to the Japan Society of Gene Therapy 19th Annual Meeting in Okayama, Japan:

“From the talks which were presented at both the AGTS and JSGT meetings, I felt that this was an exciting time for the gene therapy field as there was a strong focus on translation of pre-clinical research and the recent outcomes in various clinical trials. I had always hoped to undertake a post doctoral position in Japan and this trip allowed me to share my work with the Japanese gene therapy community and also to meet scientists and clinicians who also focus on liver-targeted gene transfer. This was a valuable and timely networking experience, as I found out during this time that I had also been awarded the JSPS Postdoctoral Fellowship for Foreign Researchers. I will therefore be undertaking a postdoctoral position at the University of Tokyo at the end of this year. I would like to thank the AGTS for helping to develop my research career and look forward to sharing my work again at future meetings.”

2011 – Dr Nham Tran


2009 – Dr Marguerite Evans-Galea

I extend my sincere thanks to all members of the AGTS Executive Committee (and the society as a whole) for welcoming me into the membership so warmly. To receive the Panos Ioannou Young Investigator Award is a great honour and privilege that was most unexpected.

Focussing on the lipid oxidative stress response in lower eukaryotes, I obtained my PhD from the University of New South Wales. From 1999 to 2007, I gained extensive postdoctoral experience in the USA. At the University of Utah I characterised proteins involved in iron and zinc homeostasis. In 2001 I accepted a fellowship at St. Jude Children’s Research Hospital in Memphis, Tennessee where I demonstrated improved lentiviral vector safety upon incorporation of an insulator. In 2008, I returned to my native Australia to join the Bruce Lefroy Centre for Genetic Health Research at the Murdoch Childrens Research Institute (MCRI). I have initiated two novel projects focused on identifying unique regulatory factors and developing potential diagnostic markers and therapies for the neurological disorder Friedreich ataxia.

My passion for gene therapy of Friedreich ataxia is akin to Prof. Ioannous own work and I have heard many anecdotal stories of his time here at the Murdoch Childrens Research Institute. Several of his fellows are now staunch colleagues and I have very much enjoyed our collaborations! It is my hope to live-up to Prof. Ioannous high standards and that of the Australasian Gene Therapy Society. To have the support of this close, cohesive group is invaluable and something I will treasure professionally and personally.

Marguerite Evans-Galea, Murdoch Childrens Research Institute

2007 – Dr Samantha Ginn

Since completing my PhD, I have applied my research-based skills to the field of gene therapy and was one of the first researchers in Australia to utilise lentiviral vectors for gene transfer protocols. I was a key member of the team involved in treating an infant with X-linked severe combined immunodeficiency at The Childrens Hospital at Westmead, an Australian biomedical first. Here, I characterised the molecular basis for the disease and analysed patient samples following gene therapy. I have a strong research focus in the field of gene therapy and am interested in targeting the bone marrow to treat immunodeficiency diseases.

My work has been recognised by the Society, being awarded the Panos Ioannou Young Investigator award in 2007. This enabled me to travel to Edinburgh for the 2008 British Society of Gene Therapy meeting as part of a reciprocal exchange. I extend my sincere thanks to the Executive and am truly grateful for the opportunity to present at the British meeting. In 2009, I became the Secretary for the Australasian Gene Therapy Society.

2005 – Dominic Glover

Dominic J. Glover is originally from Queensland. He graduated with a B.Sc. (Hons) in biochemistry from the Queensland University of Technology in 2001. His honours thesis was performed in the laboratory of Prof Martin Lavin at the Queensland Institute of Medical Research, which involved the characterization of radiation-inducible promoters for application in targeted gene therapy. For his honours thesis he was awarded a QUT Deans Award for Excellence. He then joined the Dept. of Biochemistry and Molecular Biology at Monash University to carry out his Ph.D. in the laboratory of Prof David Jans. Dominics doctoral thesis is focused on developing novel non-viral vectors that mimic the ability of viruses to be actively transported to and maintained in the cell nucleus.

“I was very honoured to receive the Panos Ioannou Young Investigator Award. The prize money will be used for travel costs to the 2005 Sir Mark Oliphant BioNano conference at the University of Queensland in late 2005.”